KCFA
GRTS

Key Client Fiduciary Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Key Client Fiduciary Advisors’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,229
Closed -$25K – 119
2022
Q2 		$25K Buy
+10,229
New +$26.9K 0.02% 112

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Key Client Fiduciary Advisors's GRTS Position: Q3 2022 in Review

Key Client Fiduciary Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2022, closing a stake of 10,229 shares — an estimated $25K sold.

Key Client Fiduciary Advisors first reported a position in GRTS in Q2 2022 and held it in 1 quarter. The position peaked at $25K in Q2 2022. 79 funds tracked by Wall St. Rank hold GRTS as of Q3 2022.

  • Key Client Fiduciary Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Key Client Fiduciary Advisors sold 10,229 Gritstone bio, Inc. Common Stock shares in Q3 2022, an estimated $25K.
  • Key Client Fiduciary Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Key Client Fiduciary Advisors's Gritstone bio, Inc. Common Stock position peaked at $25K in Q2 2022.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2022.

Based on Key Client Fiduciary Advisors's 13F filing for Q3 2022, filed 12 Oct 2022.